Grant of Exclusive Distribution Rights Sample Clauses

Grant of Exclusive Distribution Rights. A. SEYCHELLE hereby grants to DISTRIBUTOR the exclusive right to distribute and sell each of the Products within the The Territory for and during an initial period of five (5) years commencing on April 1, 2006, and ending on March 31, 2011. Details are provided in Section (vi) below. .
AutoNDA by SimpleDocs
Grant of Exclusive Distribution Rights. 2.1 Subject to the terms and conditions of this Agreement, the Company hereby grants to the Distributor the exclusive right to market, distribute and sell the Products to the Retail Market within the Territory for the Term of this Agreement (the "Distribution Rights"). The Distribution Rights will include the following rights:
Grant of Exclusive Distribution Rights. (a) Except as otherwise provided in this Agreement, BLP shall have the exclusive right to market, promote, sell and distribute Drug Product within the Field and within the New Territories by any legal means. BLP acknowledges that Pharmos has no right or authority to grant exclusive rights to market, promote, sell and distribute specific Drug Product in any country in which Pharmos does not own or otherwise have a valid license to any patent or patent application protecting such Drug Product or the Drug Substance, and in such countries the rights granted to BLP under this Agreement shall be non-exclusive. Pharmos agrees that while this Agreement is in effect it shall not grant to any third party any license or other rights to use any unpatented or unpatentable proprietary information owned by Pharmos to make, have made, sell or distribute Drug Product in any of the New Territories, except as contemplated by this Agreement. Subject to the terms of this Agreement, BLP agrees to use, or cause distributors to use, commercially reasonable efforts (but in any event efforts consistent with those used by BLP or its affiliates with respect to their own proprietary ophthalmic products in the New Territories generally) to effect the sale of Drug Product in the New Territories in a manner designed to achieve or exceed the Sales Forecast for each Product Year during the term of this Agreement. In addition, BLP agrees that it will use good faith, commercially reasonable efforts to obtain and thereafter maintain Exclusive Marketing Rights, in the name of Pharmos, wherever obtainable in each country within the New Territories for each Drug Product which may at any time during the term of this Agreement be distributable in any such country, provided, that subject to the -------- applicable terms of this Agreement, BLP or its local distributor shall be entitled to obtain and thereafter maintain such Exclusive Marketing Rights in any such country within the New Territories in the name of BLP or such local distributor if the applicable Regulatory Act in such country within the New Territories does not permit the registration of such Exclusive Marketing Rights in the name of Pharmos.
Grant of Exclusive Distribution Rights. During the term of this Agreement, “Party B” grants “Party A” the right to exclusively sell the “Products” in the “Territories” defined below (the “Exclusive Distribution Rights”).
Grant of Exclusive Distribution Rights. (a) Except as otherwise provided in this Agreement, BLP shall have the exclusive right to market, sell and distribute Drug Product within the Field and within the Territory and within the Field by any legal means. Subject to the terms of this Agreement, BLP agrees to use not less than the same effort used by BLP with respect to its own proprietary ophthalmic products to effect the sale of Drug Product in a manner designed to achieve or exceed the Sales Forecast for each Product Year during the term of this Agreement.
Grant of Exclusive Distribution Rights. Ovation agrees to grant to SJE the exclusive right to market, sell and distribute Septic Appliances and certain other products pursuant to the terms and conditions of the Distribution Agreement attached hereto as Exhibit 6.
Grant of Exclusive Distribution Rights. 2.1. MAKER hereby grants to DISTRIBUTOR an exclusive right to use, market, sell and offer for sale the Products in the Territory.
AutoNDA by SimpleDocs
Grant of Exclusive Distribution Rights 

Related to Grant of Exclusive Distribution Rights

  • Grant of Exclusive License 1. Licensor hereby grants to Licensee an exclusive worldwide license with the right to sublicense others, to make, have made, use, sell and lease the Products described in the Licensed Patent Rights with reach-through rights reserved to Licensor.

  • Exclusive License Grant Subject to the terms and conditions of this Agreement, Licensee hereby grants to Takeda an exclusive, sublicensable (subject to Section 3.3 (Sublicensing)), royalty-bearing right and license under the Licensee Technology and Licensee’s interest in the Joint Technology to Exploit the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Field in the Takeda Territory.

  • Non-Exclusive License Grant Subject to the terms and conditions of this Agreement, Takeda hereby grants to Licensee a non-exclusive, sublicensable (subject to Section 3.3 (Sublicensing)) right and license under the Takeda Technology and Takeda’s interest in the Joint Technology to: (a) Develop the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Men’s Health Field in the Takeda Territory solely for the purpose of Exploiting such Licensed Products in the Field in the Licensee Territory, or as required in order for Licensee to comply with its diligence obligations set forth in Section 5.2 (Development Diligence Obligations) and (b) Manufacture the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Takeda Territory.

  • Exclusive License Licensor hereby grants to Licensee and Licensee hereby accepts from Licensor, upon the terms and conditions herein specified, a sole and exclusive license under the Licensed Patent Rights in the Territory, and in the Field of Use to develop, make, have made, import, have imported, use, offer to sell, sell and otherwise commercialize Licensed Product(s).

  • Exclusive Service Employee shall devote his best efforts and full time to rendering services on behalf of the Corporation in furtherance of its best interests. Employee shall comply with all policies, standards and regulations of the Corporation now or hereafter promulgated, and shall perform his duties under this Agreement to the best of his abilities and in accordance with standards of conduct applicable to officers of banks.

  • Termination of Exclusivity Section 9.1 (Exclusivity in Michigan) of this Agreement shall terminate upon any termination of the Agreements, notwithstanding any breach of the Agreements by the Band.

  • Termination of License Agreement Without limiting the generality of the foregoing, in the event that the License Agreement is terminated in accordance with its terms, this Agreement, including without limitation any Purchase Order(s) or Project Work Orders then-in-effect, shall automatically terminate in its entirety as of the effective date of termination of the License Agreement.

  • Grant of Sublicense Subject to the terms and conditions of this Agreement, Adviser hereby grants to the Trust a non-transferable sublicense to use the Index (and associated data and information) listed on Exhibit A in the manner set forth in, and subject to the terms of, the License Agreement.

  • License of Data; Warranty; Termination of Rights A. The valuation information and evaluations being provided to the Trust by USBFS pursuant hereto (collectively, the “Data”) are being licensed, not sold, to the Trust. The Trust has a limited license to use the Data only for purposes necessary to valuing the Trust’s assets and reporting to regulatory bodies (the “License”). The Trust does not have any license nor right to use the Data for purposes beyond the intentions of this Agreement including, but not limited to, resale to other users or use to create any type of historical database. The License is non-transferable and not sub-licensable. The Trust’s right to use the Data cannot be passed to or shared with any other entity. The Trust acknowledges the proprietary rights that USBFS and its suppliers have in the Data.

  • Consideration for Grant of Rights (a) License Issue Fee and Patent Cost Reimbursement. COMPANY shall deliver to M.I.T. a license issue fee of Five Thousand Dollars ($5,000) on the EFFECTIVE DATE and shall pay actual unreimbursed patent expenses as described in Section 6.3. These payments are nonrefundable.

Time is Money Join Law Insider Premium to draft better contracts faster.